A Time-Resolved Fluorescence Assay to Identify Small-Molecule Inhibitors of HIV-1 Fusion

Abstract

Fusion of host cell and human immunodeficiency virus type 1 (HIV-1) membranes is mediated by the 2 “heptad-repeat” regions of the viral gp41 protein. The collapse of the C-terminal heptad-repeat regions into the hydrophobic grooves of a coiled-coil formed by the corresponding homotrimeric N-terminal heptad-repeat regions generates a stable 6-helix bundle. This brings viral and cell membranes together for membrane fusion, facilitating viral entry. The authors developed an assay based on soluble peptides derived from the gp41 N-terminal heptad-repeat region (IQN36) as well as from the C-terminal region (C34). Both peptides were labeled with fluorophores, IQN36 with allophycocyanin (APC) and C34 with the lanthanide europium (Eu3+). Formation of the 6-helix bundle brings both fluorophores in close proximity needed for Förster resonance energy transfer (FRET). Compounds that interfere with binding of C34-Eu with IQN36-APC suppress the FRET signal. The assay was validated with various peptides and small molecules, and quenching issues were addressed. Evaluation of a diversified compound collection in a high-throughput screening campaign enabled identification of small molecules with different chemical scaffolds that inhibit this crucial intermediate in the HIV-1 entry process. This study's observations substantiate the expediency of time-resolved FRET-based assays to identify small-molecule inhibitors of protein-protein interactions. (Journal of Biomolecular Screening 2007:865-874)

Keywords

HIV-1 gp41 fusion inhibitor screening Förster resonance energy transfer

References

Gallo SA , Finnegan CM , Viard M. , Raviv Y. , Dimitrov A. , Rawat SS , et al: The HIV Env-mediated fusion reaction. Biochim Biophys Acta 2003; 1614:36-50.

Eckert DM , Kim PS : Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem 2001;70:777-810.

Wild CT , Shugars DC , Greenwell TK , McDanal CB , Matthews TJ : Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 1994;91:9770-9774.

Kilby JM , Hopkins S. , Venetta TM , DiMassimo B. , Cloud GA , Lee JY , et al: Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry. Nat Med 1998;4:1302-1307.

Chan DC , Fass D. , Berger JM , Kim PS : Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997;89:263-273.

Chan DC , Chutkowski CT , Kim PS : Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target. Proc Natl Acad Sci USA 1998;95:15613-15617.

Lu M. , Blacklow SC , Kim PS : A trimeric structural domain of the HIV-1 transmembrane glycoprotein. Nat Struct Biol 1995;2:1075-1082.

Root MJ , Steger HK : HIV-1 gp41 as a target for viral entry inhibition. Curr Pharm Des 2004;10:1805-1825.

Liu S. , Jiang S. : High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques. Curr Pharm Des 2004;10:1827-1843.

10.

Ryu J-R. , Lee J. , Choo S. , Yoon SH , Woo E-R. , Yu YG : Development of an in vitro assay system for screening of gp41 inhibitory compounds . Mol Cells 1998;8:717-723.

11.

Jin B-S. , Lee W-K. , Ahn K. , Lee MK , Yu YG : High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41. J Biomol Screen 2005;10:13-19.

12.

Mo H. , Konstantinidis AK , Stewart KD , Dekhtyar T. , Ng T. , Swift K. , et al: Conserved residues in the coiled-coil pocket of human immunodeficiency virus type 1 gp41 are essential for viral replication and interhelical interaction . Virology 2004;329:319-327.

13.

Frey G. , Rits-Volloch S. , Zhang X-Q. , Schooley RT , Chen B. , Harrison SC : Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion. Proc Natl Acad Sci USA 2006;103:13938-13943.

14.

Gochin M. , Savage R. , Hinckley S. , Cai L. : A fluorescence assay for rapid detection of ligand binding affinity to HIV-1 gp41. Biol Chem 2006;387: 477-483.

15.

Hemmilä I. , Webb S. : Time-resolved fluorometry: an overview of the labels and core technologies for drug screening applications. Drug Discov Today 1997;2:373-381.

16.

Selvin PR : Principles and biophysical applications of lanthanide-based probes. Annu Rev Biophys Biomol Struct 2002;31:275-302.

17.

Eckert DM , Malashkevich VN , Kim PS : Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residues . J Mol Biol 1998; 284:859-865.

18.

Lu M. , Kim PS : A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein. J Biomol Struct Dyn 1997;15:465-471.

19.

Mathis G. : Rare earth cryptates and homogeneous fluoroimmunoassays with human sera. Clin Chem 1993;39:1953 -1959.

20.

Lambert DM , Zhou J. , Medinas R. : HIV-1 isolates from patients treated with T-20 are sensitive to the second generation fusion inhibitor T-1249. Paper presented at the Third International Workshop on Drug Resistance and Treatment Strategies , San Diego, June 23-26, 1999.

21.

Greenberg ML , Davison D. , Jin L. , Mosier S. , Melby T. , Sista P. , et al: In vitro antiviral activity of T-1249 a second generation fusion inhibitor. Antivir Ther 2002;7:S10.

22.

Liu S. , Lu H. , Niu J. , Xu Y. , Wu S. , Jiang S. : Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J Biol Chem 2005;280:11259-11273.

23.

Wang S. , York J. , Shu W. , Stoller MO , Nunberg JH , Lu M. : Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion. Biochemistry 2002;41:7283-7292.

24.

De Clercq E. : Emerging anti-HIV drugs. Expert Opin Emerg Drugs 2005; 10:241-274.

25.

Zhao X. , Singh M. , Malashkevich VN , Kim PS : Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 2000;97:14172-14177.

26.

Inglese J. , Auld DS , Jadhav A. , Johnson RL , Simeonov A. , Yasgar A. , et al: Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries . Proc Natl Acad Sci USA 2006;103:11473-11478.